Sort by: after hours % change | delayed % change | gain open | gain high | gain close | publishing date
entities : Alkermes plc symbols : LLY save search
Global CNS Therapeutics Strategic Business Report 2023: Burgeoning Global Aging Populace, Longer Life Expectancy to Drive CNS Demand
Published: 2023-06-30 (Crawled : 23:00) - prnewswire.com
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
| Email alert
Add to watchlist
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
NBIX | News M | $140.11 4.83% 4.6% 1.6M
|
Health Technology
| Email alert
Add to watchlist
SNYNF | News | $92.7 -2.18% 600K
|
Health Technology
| Email alert
Add to watchlist
UCBJY | $64.93 -4.38% 6.2K
|
Manufacturing
| Email alert
Add to watchlist
UCBJF | $128.725 -39.66% 750
|
Health Technology
| Email alert
Add to watchlist
AZNCF | News | $138.73 -4.19% 3.7K
|
Health Technology
| Email alert
Add to watchlist
PFE | News A | $26.32 0.23% 0.0% 24M
|
Health Technology
| Email alert
Add to watchlist
TAK | News | $13.38 0.15% 0.9% 1.7M
|
Health Technology
| Email alert
Add to watchlist
NVSEF | News | $95.11 6.88% 490
|
Health Technology
| Email alert
Add to watchlist
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
| Email alert
Add to watchlist
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
| Email alert
Add to watchlist
AZN | News | $70.85 1.03% 1.02% 5.6M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
| Email alert
Add to watchlist
SNY | News | $47.69 1.15% 1.13% 1.7M
|
Health Technology
| Email alert
Add to watchlist
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
| Email alert
Add to watchlist
report business life global therapeutics
Generic Central Nervous System Drugs Global Market Report 2023: Major Players Include Otsuka Pharmaceutical, Astra Zeneca, Shire, Novartis and Teva Pharmaceutical Industries
Published: 2023-06-19 (Crawled : 00:00) - prnewswire.com
NVSEF | News | $95.11 6.88% 490
|
Health Technology
|
| O: 0.02%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -0.39%
H: 0.06%
C: -0.61%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -1.0%
H: 0.32%
C: -0.52%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.41%
H: 2.02%
C: 1.37%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -1.11%
H: 1.35%
C: 0.53%
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: 0.47%
H: 0.46%
C: 0.28%
report global system novartis teva market
Alkermes Issues Letter to Shareholders Highlighting Skills and Experience of Refreshed Board of Directors
Published: 2023-06-13 (Crawled : 11:00) - investor.alkermes.com
ENDPQ | News | $0.0007 -50.0% 1K
|
n/a
|
| O: -47.17%
H: 110.71%
C: 96.43%
IRM A | $76.6 0.99% 0.0% 770K
|
Finance
|
| O: -0.18%
H: 0.94%
C: 0.2%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -0.37%
H: 0.84%
C: 0.46%
AMRX | $5.4 0.56% 0.56% 1.4M
|
Health Technology
|
| O: 0.4%
H: 8.7%
C: 1.98%
ZLAB | $15.13 0.93% 0.93% 470K
|
Health Technology
|
| O: 0.94%
H: 0.0%
C: -0.93%
VRTX | $404.93 1.25% 1.43% 1.1M
|
Health Technology
|
| O: 0.08%
H: 1.04%
C: 0.36%
UTHR | $234.445 0.16% 0.16% 420K
|
Health Technology
|
| O: -0.65%
H: 2.13%
C: 1.37%
RARE F | $45.06 3.14% 3.04% 840K
|
Health Technology
|
| O: 0.72%
H: 2.22%
C: 0.5%
SRPT | $117.065 0.09% 0.09% 440K
|
Health Technology
|
| O: 0.55%
H: 2.23%
C: -0.71%
SAGE | $12.94 0.39% 0.39% 810K
|
Health Technology
|
| O: 0.07%
H: 2.89%
C: 1.85%
PTCT | News S | $25.38 -2.27% -2.32% 750K
|
Health Technology
|
| O: -0.3%
H: 2.48%
C: 1.97%
PRTA 4 | $20.565 -3.41% -3.53% 440K
|
Health Technology
|
| O: 0.29%
H: 5.34%
C: 4.38%
NBIX | News M | $140.11 4.83% 4.6% 1.6M
|
Health Technology
|
| O: 0.05%
H: 2.35%
C: 2.29%
MDXG | $6.505 2.28% 2.23% 750K
|
Health Technology
|
| O: 0.85%
H: 1.34%
C: -0.17%
LPTX | $3.24 0.94% 0.93% 89K
|
Health Technology
|
| O: 0.0%
H: 9.63%
C: 9.63%
JAZZ | $109.685 0.79% 0.78% 380K
|
Health Technology
|
| O: -0.02%
H: 1.93%
C: 1.16%
IRWD | $8.305 3.04% 2.95% 2.1M
|
Health Technology
|
| O: 0.0%
H: 0.35%
C: -3.42%
IONS | $41.85 1.9% 1.86% 630K
|
Health Technology
|
| O: 0.17%
H: 1.25%
C: 0.46%
INFI | $0.016 12.5% 1.1M
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -5.76%
INCY | $51.62 -0.58% -0.58% 2.5M
|
Health Technology
|
| O: -0.48%
H: 1.44%
C: 0.24%
IDXX | $494.0 3.01% 2.92% 540K
|
Health Technology
|
| O: 0.31%
H: 1.9%
C: 1.42%
EXEL | $23.295 1.86% 1.82% 1.9M
|
Health Technology
|
| O: 0.05%
H: 0.89%
C: 0.52%
CYCN | $3.05 -12.54% 130
|
Health Technology
|
| O: 6.44%
H: 0.41%
C: -1.94%
BPMC | $92.32 1.89% 1.85% 790K
|
Health Technology
|
| O: 0.62%
H: 2.47%
C: 0.53%
AXLA | $4.58 -56.33% 42K
|
Health Technology
|
| O: -1.06%
H: 6.94%
C: -2.15%
ALNY | $146.06 0.19% 0.18% 540K
|
Health Technology
|
| O: 0.07%
H: 2.64%
C: 2.23%
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: 0.19%
H: 1.58%
C: 0.64%
ACAD | News | $16.735 -1.5% -1.52% 1.5M
|
Health Technology
|
| O: 0.12%
H: 1.83%
C: 1.58%
IBIO | $1.9 6.74% 0.0% 150K
|
Health Technology
|
| O: 16.68%
H: 3.53%
C: -11.59%
Depression Drugs Market to Surpass US$ 20 Billion by 2031 as Demand for Serotonin-norepinephrine Reuptake Inhibitors Surges
Published: 2022-08-11 (Crawled : 14:00) - prnewswire.com
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: 0.0%
NVS | News | $97.28 2.27% 0.31% 3.7M
|
Health Technology
|
| O: -1.83%
H: 0.79%
C: -0.29%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -1.18%
H: 1.46%
C: 0.05%
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: -0.08%
H: 0.51%
C: -0.62%
depression market
Outlook on the Antidepressant Drugs Global Market to 2030 - Featuring Alkermes, AbbVie and GlaxoSmithKline Among Others
Published: 2022-06-17 (Crawled : 19:00) - prnewswire.com
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
| Email alert
Add to watchlist
TEVJF | News | $12.37 -24.22% 380
|
Health Technology
| Email alert
Add to watchlist
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
| Email alert
Add to watchlist
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
| Email alert
Add to watchlist
market drug
Global Schizophrenia Drugs Market Research Report 2022-2027 - Increasing Admission to The Internet Facilities Globally Boosts the Market for Online Pharmacies
Published: 2022-04-26 (Crawled : 20:00) - prnewswire.com
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 3.86%
H: 0.18%
C: 0.18%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.77%
H: 0.0%
C: 0.0%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: 1.73%
H: 1.53%
C: 0.62%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.21%
H: 0.0%
C: 0.0%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: 0.0%
VNDA | $4.63 -3.54% -3.67% 1.4M
|
Health Technology
|
| O: 0.2%
H: 1.56%
C: -1.17%
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: 13.01%
H: 2.29%
C: -0.95%
internet research report schizophrenia market
Valued to be $6.8 Billion by 2026, Bipolar Disorder Therapeutics Slated for Robust Growth Worldwide
Published: 2022-02-18 (Crawled : 16:00) - prnewswire.com
ALPMF | News | $9.75 43.47% 200
|
Health Technology
|
| O: -0.84%
H: 0.0%
C: 0.0%
GLAXF | News | $20.305 -14.18% 630
|
Health Technology
|
| O: 0.0%
H: 0.0%
C: -2.14%
ALPMY | News | $9.53 -1.11% 690K
|
Manufacturing
|
| O: -4.37%
H: 3.61%
C: 3.06%
JNJ | News | $149.56 0.3% 0.0% 9.1M
|
Health Technology
|
| O: -0.73%
H: 0.23%
C: -0.98%
GSK | News | $41.24 1.6% 0.0% 2.3M
|
Health Technology
|
| O: -0.46%
H: 0.46%
C: -0.19%
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: -1.22%
H: 1.85%
C: 0.96%
BMY | $48.99 -0.31% 0.0% 9.1M
|
Health Technology
|
| O: -0.01%
H: 0.79%
C: 0.25%
ABBV | News | $169.54 0.98% -0.91% 4.1M
|
Health Technology
|
| O: -0.19%
H: 0.72%
C: -0.46%
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: -0.71%
H: 3.54%
C: -0.36%
order therapeutics growth
Alkermes Announces Commercial Availability of LYBALVI® for the Treatment of Schizophrenia and Bipolar I Disorder
Published: 2021-10-18 (Crawled : 19:00) - biospace.com/
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.14%
H: 1.98%
C: 0.43%
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: 0.03%
H: 0.0%
C: -4.36%
treatment schizophrenia commercialization
Alkermes Announces FDA Approval of LYBALVI™ for the Treatment of Schizophrenia and Bipolar I Disorder
Published: 2021-06-01 (Crawled : 11:00) - investor.alkermes.com
LLY | News | $745.69 1.96% -0.16% 2M
|
Health Technology
|
| O: 0.29%
H: 0.28%
C: -0.95%
ALKS | $24.26 0.79% 0.78% 1.2M
|
Health Technology
|
| O: 0.79%
H: 1.4%
C: 1.31%
treatment fda schizophrenia fda approval approval
Gainers vs Losers
| 78% | 22% |
Top 10 Gainers
MTTR | News M | $4.6 164.37% 62.17% 28M
|
AGBA | $2.94 135.2% 57.48% 66M
|
Finance
EDBL | News | $6.46 71.81% 41.8% 2M
|
MTC | $2.25 44.23% 30.67% 6M
|
Technology Services
OPRT | News | $3.175 41.11% 29.13% 12M
|
Finance
SHIM | $3.05 35.56% 26.23% 1.1M
|
HKIT | $1.345 31.86% 24.16% 390K
|
Technology Services
ABVC | $1.36 30.77% 23.53% 7.4M
|
Wholesale Trade
OST | $0.512 28.0% 21.88% 290K
|
POET | $1.59 27.2% 21.38% 4.2M
|
Manufacturing
Your saved searches
Save your searches and get alerts when important news are released.